-+ 0.00%
-+ 0.00%
-+ 0.00%
Hamlet BioPharma sets July 20-31 TO5B warrant exercise window, terms at SEK 6 per share
Share
Listen to the news
Hamlet BioPharma sets July 20-31 TO5B warrant exercise window, terms at SEK 6 per share
  • Hamlet Biopharma set the ordinary exercise window for TO5B warrants for July 20–31, 2026.
  • About 1,500,000 TO5B warrants were early exercised in April 2026 at SEK 6 per share, raising about SEK 9 million.
  • Roughly 5,400,000 TO5B warrants remain outstanding; full exercise would add about SEK 32 million in proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hamlet Biopharma AB published the original content used to generate this news brief via Cision (Ref. ID: 202607170326BITN____UKPR__SV_20260717-BIT-9887-0) on July 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending